Parker-Hannifin Corporation Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $87.4 Billion | 2/12 | ETN $122.5B |
PH $87.4B |
ITW $75.6B |
EMR $70.2B |
CMI $50.0B |
ROK $34.1B |
DOV $27.6B |
PNR $16.2B |
IEX $14.7B |
GGG $14.4B |
AOS $9.5B |
FLS $8.1B |
Gross Margin | 37% | 9/12 | EMR 100% |
ROK 100% |
GGG 51% |
ITW 44% |
IEX 44% |
ETN 40% |
DOV 39% |
PNR 39% |
PH 37% |
AOS 37% |
FLS 32% |
CMI 26% |
Profit Margin | 14% | 8/12 | DOV 74% |
ITW 29% |
ROK 25% |
GGG 20% |
PNR 17% |
ETN 16% |
IEX 15% |
PH 14% |
EMR 14% |
AOS 12% |
CMI 10% |
FLS 5% |
EBITDA margin | 18% | 7/12 | ITW 39% |
ROK 34% |
GGG 24% |
IEX 21% |
PNR 20% |
ETN 19% |
PH 18% |
AOS 17% |
DOV 15% |
EMR 14% |
FLS 11% |
CMI 7% |
Quarterly Revenue | $4.9 Billion | 3/12 | CMI $8.5B |
ETN $6.3B |
PH $4.9B |
EMR $4.2B |
ITW $4.0B |
DOV $1.9B |
FLS $1.1B |
PNR $972.9M |
AOS $912.4M |
IEX $798.2M |
ROK $722.0M |
GGG $548.7M |
Quarterly Earnings | $698.4 Million | 5/12 | DOV $1.4B |
ITW $1.2B |
ETN $1.0B |
CMI $809.0M |
PH $698.4M |
EMR $593.0M |
ROK $184.0M |
PNR $166.4M |
IEX $119.1M |
AOS $109.7M |
GGG $108.7M |
FLS $58.4M |
Quarterly Free Cash Flow | $648.7 Million | 4/12 | ETN $1.7B |
ITW $783.0M |
EMR $694.0M |
PH $648.7M |
CMI $381.0M |
ROK $293.0M |
IEX $191.6M |
FLS $154.6M |
DOV -$0 |
PNR -$0 |
AOS -$0 |
GGG -$0 |
Trailing 4 Quarters Revenue | $20.0 Billion | 3/12 | CMI $34.2B |
ETN $24.6B |
PH $20.0B |
EMR $17.6B |
ITW $15.9B |
DOV $8.2B |
FLS $4.5B |
ROK $4.4B |
PNR $4.1B |
AOS $3.8B |
IEX $3.2B |
GGG $2.1B |
Trailing 4 Quarters Earnings | $2.9 Billion | 3/12 | CMI $8.5B |
ETN $6.3B |
PH $4.9B |
EMR $4.2B |
ITW $4.0B |
DOV $1.9B |
FLS $1.1B |
PNR $972.9M |
AOS $912.4M |
IEX $798.2M |
ROK $722.0M |
GGG $548.7M |
Quarterly Earnings Growth | 7% | 7/12 | DOV 385% |
EMR 349% |
ITW 50% |
FLS 26% |
CMI 23% |
ETN 13% |
PH 7% |
GGG -1% |
ROK -14% |
PNR -20% |
AOS -20% |
IEX -43% |
Annual Earnings Growth | 4% | 5/12 | DOV 131% |
FLS 34% |
ETN 21% |
ITW 14% |
PH 4% |
PNR 3% |
EMR 2% |
AOS -2% |
GGG -5% |
ROK -18% |
IEX -22% |
CMI -26% |
Quarterly Revenue Growth | 1% | 3/12 | ETN 8% |
FLS 4% |
PH 1% |
EMR 1% |
IEX 1% |
CMI 0% |
PNR -1% |
ITW -2% |
GGG -3% |
DOV -8% |
AOS -8% |
ROK -9% |
Annual Revenue Growth | -1% | 7/12 | EMR 7% |
ETN 5% |
FLS 5% |
PNR 2% |
CMI 0% |
AOS 0% |
PH -1% |
ITW -2% |
GGG -3% |
DOV -4% |
IEX -4% |
ROK -48% |
Cash On Hand | $371.1 Million | 10/12 | EMR $2.8B |
DOV $1.8B |
CMI $1.7B |
ITW $947.0M |
GGG $675.3M |
IEX $633.2M |
FLS $611.7M |
ETN $473.0M |
ROK $471.0M |
PH $371.1M |
AOS $239.6M |
PNR $118.7M |
Short Term Debt | $3.5 Billion | 1/12 | PH $3.5B |
CMI $2.3B |
ITW $1.8B |
EMR $1.1B |
ROK $1.0B |
ETN $717.0M |
DOV $400.1M |
FLS $66.9M |
GGG $28.5M |
AOS $10.0M |
PNR $9.3M |
IEX $600,000 |
Long Term Debt | $6.7 Billion | 2/12 | ETN $9.4B |
PH $6.7B |
ITW $6.6B |
EMR $6.6B |
CMI $4.9B |
ROK $2.6B |
DOV $2.5B |
IEX $2.1B |
PNR $1.6B |
FLS $1.2B |
AOS $206.7M |
GGG $12.3M |
PE | 30.21 | 4/12 | ROK 37.09 |
ETN 32.49 |
FLS 30.41 |
PH 30.21 |
IEX 29.88 |
GGG 29.57 |
EMR 29.02 |
PNR 25.89 |
CMI 23.85 |
ITW 21.88 |
AOS 17.73 |
DOV 10.23 |
PS | 4.37 | 6/12 | ROK 7.80 |
GGG 6.80 |
ETN 4.98 |
ITW 4.74 |
IEX 4.59 |
PH 4.37 |
EMR 4.00 |
PNR 3.97 |
DOV 3.37 |
AOS 2.48 |
FLS 1.79 |
CMI 1.46 |
PB | 5.60 | 4/12 | ITW 22.29 |
ROK 10.08 |
ETN 6.39 |
PH 5.60 |
GGG 5.56 |
PNR 4.54 |
AOS 4.43 |
CMI 4.41 |
DOV 3.97 |
FLS 3.87 |
IEX 3.84 |
EMR 1.91 |
PC | 235.42 | 2/12 | ETN 258.91 |
PH 235.42 |
PNR 136.40 |
ITW 79.84 |
ROK 72.46 |
AOS 39.49 |
CMI 28.86 |
EMR 24.77 |
IEX 23.15 |
GGG 21.28 |
DOV 14.95 |
FLS 13.31 |
Liabilities to Equity | 0.90 | 6/12 | ITW 3.67 |
CMI 2.01 |
ROK 1.57 |
FLS 1.54 |
ETN 1.05 |
PH 0.90 |
IEX 0.82 |
PNR 0.81 |
DOV 0.80 |
AOS 0.52 |
EMR 0.22 |
GGG 0.21 |
ROA | 0.10 | 6/12 | DOV 22% | ITW 22% | AOS 16% | GGG 15% | ROK 11% | PH 10% | ETN 10% | PNR 10% | CMI 7% | IEX 7% | EMR 6% | FLS 5% |
ROE | 0.19 | 7/12 | ITW 102% |
DOV 39% |
ROK 27% |
AOS 25% |
ETN 20% |
CMI 20% |
PH 19% |
GGG 19% |
PNR 18% |
IEX 13% |
FLS 13% |
EMR 9% |
Current Ratio | 2.11 | 7/12 | EMR 7.24 |
GGG 5.66 |
AOS 2.94 |
DOV 2.25 |
PNR 2.24 |
IEX 2.21 |
PH 2.11 |
ETN 1.95 |
FLS 1.66 |
ROK 1.64 |
CMI 1.55 |
ITW 1.27 |
Quick Ratio | 0.03 | 12/12 | ROK 37.09 |
ETN 32.49 |
FLS 30.41 |
PH 30.21 |
IEX 29.88 |
GGG 29.57 |
EMR 29.02 |
PNR 25.89 |
CMI 23.85 |
ITW 21.88 |
AOS 17.73 |
DOV 10.23 |
Long Term Debt to Equity | 0.43 | 8/12 | ITW} 1.94 |
ROK} 0.76 |
FLS} 0.57 |
IEX} 0.54 |
ETN} 0.49 |
CMI} 0.47 |
PNR} 0.46 |
PH} 0.43 |
DOV} 0.36 |
EMR} 0.25 |
AOS} 0.10 |
GGG} 0.00 |
Debt to Equity | 0.65 | 4/12 | ITW 2.46 |
ROK 1.07 |
CMI 0.69 |
PH 0.65 |
FLS 0.60 |
IEX 0.54 |
ETN 0.53 |
PNR 0.46 |
DOV 0.42 |
EMR 0.29 |
AOS 0.10 |
GGG 0.02 |
Burn Rate | 0.83 | 3/12 | FLS 116.33 |
ROK 2.60 |
PH 0.83 |
ETN -1.04 |
PNR -1.20 |
DOV -1.49 |
ITW -2.08 |
AOS -2.42 |
GGG -6.68 |
IEX -17.62 |
CMI -41.01 |
EMR -44.13 |
Cash to Cap | 0.00 | 11/12 | FLS 0.08 |
DOV 0.07 |
GGG 0.05 |
EMR 0.04 |
IEX 0.04 |
CMI 0.03 |
AOS 0.03 |
ITW 0.01 |
PNR 0.01 |
ROK 0.01 |
PH 0.00 |
ETN 0.00 |
CCR | 0.93 | 6/12 | FLS 2.65 |
ETN 1.66 |
IEX 1.61 |
ROK 1.59 |
EMR 1.17 |
PH 0.93 |
ITW 0.68 |
CMI 0.47 |
DOV |
PNR |
AOS |
GGG |
EV to EBITDA | 111.03 | 3/12 | ROK} 151.51 |
EMR} 126.47 |
PH} 111.03 |
ETN} 109.87 |
GGG} 105.67 |
CMI} 98.27 |
DOV} 97.16 |
IEX} 95.82 |
PNR} 90.83 |
FLS} 73.33 |
AOS} 60.46 |
ITW} 54.08 |
EV to Revenue | 4.86 | 6/12 | ROK 8.52 |
GGG 6.50 |
ETN 5.37 |
ITW 5.20 |
IEX 5.04 |
PH 4.86 |
PNR 4.34 |
EMR 4.27 |
DOV 3.50 |
AOS 2.47 |
FLS 1.93 |
CMI 1.62 |